Investment ministry signs 2 deals to enhance biotechnology, pharmaceutical sector in Saudi Arabia
- First deal was signed with German-based pharmaceutical company Boehringer Ingelheim.
- Second MoU was signed with Saudi Novo Nordisk Trading Company and KAUST
